Close Menu

You may find more results for this query on our sister sites: 360Dx and Precision Oncology News.

Home » Tools & Technology » Informatics » SignalGene to Acquire GeneScape Along with $3.7 M Private Placement

SignalGene to Acquire GeneScape Along with $3.7 M Private Placement

Mar 09, 2000
Premium

M

ONTREAL--SignalGene here has agreed to acquire GeneScape, a company with drug target identification and validation technologies, in a stock transaction valued at $12.7 million. The agreement includes a private placement totaling $2.7 million by two of GeneScape’s current shareholders, the Business Development Bank of Canada and Royal Bank Venture. An additional $1 million will be invested directly into SignalGene by Societe Innovatech du Grand Montreal when the acquisition closes, expected by March 20.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

GenomeWeb Premium gives you:
✔ Full site access
✔ Interest-based email alerts
✔ Access to archives

Never miss another important industry story.

Try GenomeWeb Premium now.

You may already have institutional access!

Check if I qualify.

Already a GenomeWeb or 360Dx Premium member?
Login Now.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.

The Scan

High Numbers Reported for Russian Vaccine

Russia says its candidate SARS-CoV-2 vaccine has a very high efficacy rate in an initial analysis of clinical trial data, according to the Financial Times.

Masterpiece Microbiome

Wired reports on a microbial analysis of sketches drawn by Leonardo DaVinci.

Limited Trust

A new survey explores coronavirus vaccine hesitancy among Black and Latino individuals, the Washington Post reports.

Nucleic Acids Research Papers on Aging Atlas, Human Metagenomes, Drug Repositioning

In Nucleic Acids Research this week: the Aging Atlas database, a database of human metagenome-related metadata, and more.

Dec
15
Featured Webinar

Case Study: Deployment of High-Throughput SARS-CoV-2 Testing at UC Davis

Sponsored by
UgenTec

Diverse components of the UC Davis campus have been mobilized to deploy HTP testing to provide a safe working environment and keep the pandemic under control.

What's Popular?

In Informatics

  1. Prototype GenoShare Tool Aims to Help Patients Understand Risks of Genomic Data Sharing

    Premium

  2. Three Investment Banks Initiate Coverage of Biodesix

Sponsorships

Privacy Policy.  Terms & Conditions.  .  Copyright © 2020 GenomeWeb, a business unit of Crain Communications.  All Rights Reserved.